Sign in

CIK 0001479419

  • Non-accelerated filer
  • Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
270604595
Phone
+1 781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
  1. 4 Open-market sale SEE REMARKS sold 5,251 shares at $4.01 ($21,057)
  2. 4 Open-market sale Director sold 13,227 shares at $4.01 ($53,040)
  3. 4 Grant or award Director acquired 2,450 shares (grant or award)
  4. 4 Grant or award Director acquired 2,450 shares (grant or award)
  5. 4 Grant or award Director acquired 2,450 shares (grant or award)
  6. 4 Grant or award Director acquired 2,450 shares (grant or award)
  7. 4 Grant or award Director acquired 2,450 shares (grant or award)
  8. 4 Grant or award Director acquired 3,050 shares (grant or award)
  9. 4/A Open-market sale Director sold 10,866 shares at $3.74 ($40,639)
  10. 4 Open-market sale CHIEF BUSINESS OFFICER sold 730 shares at $3.74 ($2,730)
  11. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 2,850 shares at $3.74 ($10,659)
  12. 4 Open-market sale SEE REMARKS sold 3,390 shares at $3.74 ($12,679)
  13. 4 Open-market sale SEE REMARKS sold 3,687 shares at $3.74 ($13,789)
  14. 4 Open-market sale Director sold 10,866 shares at $3.74 ($40,639)
  15. 4 Derivatives Options or other derivatives
  16. 4/A Insider Changes in Ownership
  17. 4 Open-market sale CHIEF BUSINESS OFFICER sold 2,021 shares at $7.63 ($15,420)
  18. 4 Open-market sale SEE REMARKS sold 1,993 shares at $7.63 ($15,207)
  19. 4 Open-market sale SEE REMARKS sold 2,446 shares at $7.63 ($18,663)
  20. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 5,779 shares at $7.63 ($44,094)

Page 2 of 15 · 288 filings